457 related articles for article (PubMed ID: 10213914)
1. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus.
Karanth S; Lyson K; McCann SM
Neuroimmunomodulation; 1999; 6(3):168-74. PubMed ID: 10213914
[TBL] [Abstract][Full Text] [Related]
2. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro.
Calogero AE; Gallucci WT; Bernardini R; Saoutis C; Gold PW; Chrousos GP
Neuroendocrinology; 1988 Apr; 47(4):303-8. PubMed ID: 2897641
[TBL] [Abstract][Full Text] [Related]
3. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.
Karanth S; Lyson K; McCann SM
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3383-7. PubMed ID: 8475085
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic and muscarinic components in acetylcholine stimulation of porcine adrenal medullary cells.
Nassar-Gentina V; Catalán L; Luxoro M
Mol Cell Biochem; 1997 Apr; 169(1-2):107-13. PubMed ID: 9089637
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamic explants by releasing nitric oxide.
Rettori V; Canteros G; Renoso R; Gimeno M; McCann SM
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2741-4. PubMed ID: 9122267
[TBL] [Abstract][Full Text] [Related]
6. Evidence for presynaptic cholinergic receptors in sympathetic nerves in human dental pulp.
Parker DA; Marino V; Zisimopoulos S; de la Lande IS
Arch Oral Biol; 1998 Mar; 43(3):197-204. PubMed ID: 9631172
[TBL] [Abstract][Full Text] [Related]
7. Effects of luteinizing-hormone-releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release.
Karanth S; Lyson K; Aguila MC; McCann SM
Neuroimmunomodulation; 1995; 2(3):166-73. PubMed ID: 8646567
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
Raber J; Koob GF; Bloom FE
J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A inhibits interleukin-2-induced release of corticotropin-releasing hormone.
Karanth S; Lyson K; McCann SM
Neuroimmunomodulation; 1994 Jan; 1(1):82-5. PubMed ID: 8528889
[TBL] [Abstract][Full Text] [Related]
10. The nature of the acetylcholine and 5-hydroxytryptamine receptors in buccal smooth muscle of the pest slug Deroceras reticulatum.
Wright TJ; Huddart H
J Comp Physiol B; 2002 Apr; 172(3):237-49. PubMed ID: 11919705
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic regulation of the evoked quantal release at frog neuromuscular junction.
Nikolsky EE; Vyskocil F; Bukharaeva EA; Samigullin D; Magazanik LG
J Physiol; 2004 Oct; 560(Pt 1):77-88. PubMed ID: 15254150
[TBL] [Abstract][Full Text] [Related]
12. Control of the release of newly synthetized 3H-5-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices.
Héry F; Bourgoin S; Hamon M; Ternaux JP; Glowinski J
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):91-7. PubMed ID: 834319
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine stimulates alpha-melanocyte-stimulating hormone release from frog pituitary melanotrophs through activation of muscarinic and nicotinic receptors.
Lamacz M; Tonon MC; Louiset E; Cazin L; Strosberg D; Vaudry H
Endocrinology; 1989 Aug; 125(2):707-14. PubMed ID: 2546745
[TBL] [Abstract][Full Text] [Related]
14. Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines.
Reid MS; Nishino S; Tafti M; Siegel JM; Dement WC; Mignot E
Exp Neurol; 1998 May; 151(1):89-104. PubMed ID: 9582257
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function.
Marchi M; Raiteri M
J Neurochem; 1996 Nov; 67(5):1974-81. PubMed ID: 8863503
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic autoreceptor function in rat brain during maturation and aging: possible differential sensitivity to organophosphorus anticholinesterases.
Wu YJ; Harp P; Yan XR; Pope CN
Chem Biol Interact; 2003 Jan; 142(3):255-68. PubMed ID: 12453664
[TBL] [Abstract][Full Text] [Related]
17. Alpha-melanocyte-stimulating hormone abolishes IL-1- and IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro.
Lyson K; McCann SM
Neuroendocrinology; 1993 Aug; 58(2):191-5. PubMed ID: 8264864
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic and muscarinic acetylcholine receptors are essential for the long-term response of tyrosine hydroxylase gene expression to chronic nicotine treatment in rat adrenal medulla.
Yoshimura R; Xu L; Sun B; Tank AW
Brain Res Mol Brain Res; 2004 Jul; 126(2):188-97. PubMed ID: 15249143
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
Onali P; Olianas MC
J Pharmacol Exp Ther; 1998 Aug; 286(2):753-9. PubMed ID: 9694930
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic and muscarinic acetylcholine responses in differentiated PC12 cells.
Furukawa K; Nabekura J; Akaike N
Brain Res; 1994 Feb; 638(1-2):302-10. PubMed ID: 7911063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
